Carroll Financial Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Carroll Financial Associates’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$102K	Buy	+1,111	New	+$95.2K	0.01%	525

Other funds holding NARI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carroll Financial Associates's NARI Position: Q4 2021 in Review

Carroll Financial Associates opened a new position in Inari Medical, Inc. Common Stock (NARI) in Q4 2021: 1,111 shares worth $102K. The stake represents 0.01% of the portfolio and ranks #525 among its holdings.

192 funds tracked by Wall St. Rank hold NARI as of Q4 2021.

Carroll Financial Associates held 1,111 shares of Inari Medical, Inc. Common Stock worth $102K as of Q4 2021.
Inari Medical, Inc. Common Stock was a new Carroll Financial Associates position in Q4 2021.
Inari Medical, Inc. Common Stock made up 0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #525 holding.
192 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.